overview of the updated nccn clinical practice guidelines for systemic al amyloidosis
Published 1 year ago • 116 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
5:14
current status & updates in the management of al amyloidosis
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:16
considering enrolment in clinical trials for patients with amyloidosis
-
4:05
al amyloidosis special session highlights: therapeutic advances and ongoing trials in the field
-
5:37
real-world application of nccn guidelines in cll/sll
-
2:32
ongoing trials in amyloidosis
-
1:30
ongoing trials on antibody treatments for al amyloidosis
-
9:53
key highlights in amyloidosis at ash 2023: diagnosis & novel immunotherapeutic agents being explored
-
54:52
hiv & hematology | the national em board (myemcert) review course
-
36:35
linc 2023 - treatment of clti: new horizons with novel dcb technology
-
4:48
the top 10 most promising medical technologies updated - the medical futurist
-
2:41
an overview of the latest advances in hematology
-
1:39
new clinical trial results in cardiac and peripheral nerve amyloidosis
-
52:09
august 26, 2024 id vmr w/dr. dan minter & dr. uttara gadde - first episode of tonic clonic seizure
-
19:06
nccm 2024 | emerging role of digital morphology in precision diagnostics by dr tan yuen fen
-
1:51
diagnosis and potential therapeutic options for aa amyloidosis
-
2:48
an overview of trials in progress in al amyloidosis: highlights from isa 2024
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:38
diagnostic and clinical impact of the revised definition of light chain mgus
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions